Ferrostatin-1 post-treatment attenuates acute kidney injury in mice by inhibiting ferritin production and regulating iron uptake-related proteins
PeerJ · 2023
DOI: 10.7717/peerj.15786 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2023. Verfasst von Yanxiu Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Baoshan People's Hospital, Baoshan, People's Republic of China. Hauptthemen laut MEDLINE: Ferritins, Acute Kidney Injury. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Acute kidney injury (AKI) is a common and serious medical condition with high morbidity and mortality. Recent research has highlighted ferroptosis, a novel form of programmed cell death, as a potential therapeutic target in mitigating renal tubular injury in AKI. Ferrostatin-1, a specific ferroptosis inhibitor, has been demonstrated to prevent renal injury through ferroptosis inhibition.
Methods
Utilizing a murine AKI model, we investigated the effects of Ferrostatin-1 by administering it post-injury. Through high-throughput sequencing and pathological analysis, we focused on the critical role of ferroptosis-related pathways in the treatment.
Results
Ferrostatin-1 post-conditioning effectively mitigated oxidative damage and reduced iron content associated with AKI. Additionally, critical ferroptosis-related proteins, such as GPX4, SLC7A11, NRF2, and FTH1, exhibited increased expression levels. In vitro , Ferrostatin-1 treatment of HK-2 cells significantly diminished lipid peroxidation and iron accumulation. Furthermore, Ferrostatin-1 was found to downregulate the PI3K signalling pathway.
Conclusion
Ferrostatin-1 acted as a potential ferroptosis inhibitor with the capacity to enhance antioxidant defences. This study suggests that Ferrostatin-1 could serve as a promising novel strategy for improving the treatment of AKI and promoting recovery from the condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Baoshan People's Hospital, Baoshan, People's Republic of China.
- Department of Obstetrics, Baoshan People's Hospital, Baoshan, People's Republic of China.
- Department of Pediatrics, Baoshan People's Hospital, Baoshan, People's Republic of China.
- Intensive Care Unit, Ningbo Medical Center Lihuili Hospital, Ningbo, People's Republic of China.
Zitieren
APA
Zhao, Y., Jiang, B., Huang, D., Lou, J., Li, G., Liu, J., Duan, F., Yuan, Y., & Su, X. (2023). Ferrostatin-1 post-treatment attenuates acute kidney injury in mice by inhibiting ferritin production and regulating iron uptake-related proteins. PeerJ. https://doi.org/10.7717/peerj.15786
Vancouver
Zhao Y, Jiang B, Huang D, Lou J, Li G, Liu J, et al. Ferrostatin-1 post-treatment attenuates acute kidney injury in mice by inhibiting ferritin production and regulating iron uptake-related proteins. PeerJ. 2023. doi:10.7717/peerj.15786
BibTeX
@article{Zhao2023,
author = {Zhao, Yanxiu and Jiang, Binhua and Huang, Dinghui and Lou, Juxiang and Li, Guoshun and Liu, Jianqi and Duan, Fuhui and Yuan, Yuan and Su, Xiaoyan},
title = {Ferrostatin-1 post-treatment attenuates acute kidney injury in mice by inhibiting ferritin production and regulating iron uptake-related proteins},
journal = {PeerJ},
year = {2023},
doi = {10.7717/peerj.15786}
}
EUVIMED